非小细胞肺癌患者治疗前症状、急性和晚期毒性反应与患者报告健康相关生活质量的相关性:REQUITE研究结果
REQUITE国际真实世界研究分析了435例接受局部区域放疗的早期和局部晚期非小细胞肺癌患者,采用常见不良事件评价标准第4版评估11项放疗相关毒性,用EORTC-QLQ-C30评估健康相关生活质量。混合模型分析显示治疗前症状及急性/晚期毒性以不同方式影响生活质量,呼吸困难在整个病程中似乎起关键作用,数据呼吁优化放疗以限制可能影响生活质量的毒性。
要点
- 治疗前整体症状、呼吸困难、胸壁痛、吞咽困难和咳嗽影响整体生活质量及特定领域。
- 后续时间点咳嗽和吞咽困难被心包炎超越,同步放化疗和三维放疗的毒性对生活质量影响最大。
- 局部晚期患者受毒性不利影响大于早期患者,呼吸困难在整个病程中似乎关键。
核心结论
- 治疗前症状和急性/晚期毒性以不同方式影响接受不同治疗方式和放疗技术的早期和局部晚期非小细胞肺癌患者的健康相关生活质量。
- 在整个病程中,呼吸困难似乎在这一关联中起关键作用,突显共存合并症的额外影响。
- 作者认为数据呼吁优化放疗以限制可能影响患者生活质量的毒性。
研究设计与样本
- 国际真实世界REQUITE研究,纳入接受局部区域放疗的早期和局部晚期非小细胞肺癌患者,分析435例患者数据。
- 临床医生采用常见不良事件评价标准第4版评估11项放疗相关毒性及基线症状。
- 采用欧洲癌症研究与治疗组织核心生活质量问卷(EORTC-QLQ-C30)评估健康相关生活质量。
- 统计分析采用混合模型方法,统计学显著性设定为p=0.01。
- 分析涵盖基线及放疗后至2年的后续时间点,并按治疗方式、放疗技术和疾病分期分层。
主要发现
- 治疗前整体症状、呼吸困难、胸壁痛、吞咽困难和咳嗽影响整体健康相关生活质量及特定领域。
- 后续时间点,咳嗽和吞咽困难在影响健康相关生活质量方面被心包炎超越。
- 同步放化疗和三维放疗期间的毒性对健康相关生活质量影响最大。
- 序贯放化疗和立体定向体部放疗(SBRT)的毒性对患者健康相关生活质量影响有限。
- 分期影响相关性:局部晚期非小细胞肺癌患者受毒性不利影响大于早期患者,与放疗技术和治疗方式的结果相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To investigate the association between clinician-scored toxicities and patient-reported health-related quality of life (HRQoL), in early-stage (ES-) and locally-advanced (LA-) non-small cell lung cancer (NSCLC) patients receiving loco-regional radiotherapy, included in the international real-world REQUITE study. MATERIALS AND METHODS: Clinicians scored eleven radiotherapy-related toxicities (and baseline symptoms) with the Common Terminology Criteria for Adverse Events version 4. HRQoL was assessed with the European Organization for Research and Treatment of Cancer core HRQoL questionnaire (EORTC-QLQ-C30). Statistical analyses used the mixed-model method; statistical significance was set at p = 0.01. Analyses were performed for baseline and subsequent time points up to 2 years after radiotherapy and per treatment modality, radiotherapy technique and disease stage. RESULTS: Data of 435 patients were analysed. Pre-treatment, overall symptoms, dyspnea, chest wall pain, dysphagia and cough impacted overall HRQoL and specific domains. At subsequent time points, cough and dysphagia were overtaken by pericarditis in affecting HRQoL. Toxicities during concurrent chemo-radiotherapy and 3-dimensional radiotherapy had the most impact on HRQoL. Conversely, toxicities in sequential chemo-radiotherapy and SBRT had limited impact on patients' HRQoL. Stage impacts the correlations: LA-NSCLC patients are more adversely affected by toxicity than ES-NSCLC patients, mimicking the results of radiotherapy technique and treatment modality. CONCLUSION: Pre-treatment symptoms and acute/late toxicities variously impact HRQoL of ES- and LA-NSCLC patients undergoing different treatment approaches and radiotherapy techniques. Throughout the disease, dyspnea seems crucial in this association, highlighting the additional effect of co-existing comorbidities. Our data call for optimized radiotherapy limiting toxicities that may affect patients' HRQoL.
引用
- van der Weijst L, Azria D, Berkovic P, et al. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. Radiother Oncol. 2022. PMID: 36195214. doi:10.1016/j.radonc.2022.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。